Form 4 Filing for ANI Pharmaceuticals Inc.

Stephen P. Carey, SVP & CFO of ANI Pharmaceuticals Inc., reported a sale of 2,850 shares of Common Stock on August 31, 2026. The sale was executed as part of a Rule 10b5-1 trading plan. The weighted average sale price was $72.80 per share, with individual sales ranging from $71.89 to $73.36. Following this transaction, Mr. Carey owns 171,843 shares of Common Stock. This filing is a standard disclosure of insider transactions.